Skip to main content
Erschienen in: Journal of Natural Medicines 1/2015

01.01.2015 | Note

Screening of β-secretase and acetylcholinesterase inhibitors from plant resources

verfasst von: Kazuya Murata, Shinichi Matsumura, Yuri Yoshioka, Yoshihiro Ueno, Hideaki Matsuda

Erschienen in: Journal of Natural Medicines | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

The therapeutic agents for dementia are limited due to the complex system underlying the mechanisms. Taking a preventive point of view, we focused on the inhibition of β-secretase and acetylcholinesterase (AChE). In addition, plant resources including herbs and spices have been widely consumed, and further, may be consumed for a long period over a lifetime. Considering this background, we screened β-secretase and AChE inhibitors from curry spices. Amongst them, curry leaf, black pepper, and turmeric extracts were effective to inhibit β-secretase. Furthermore, black pepper and turmeric extracts were also effective to inhibit AChE. Having these results in hand, we focused on the investigation of β-secretase inhibitors since the inhibitor of this enzyme has not previously been well investigated. As a result, α- and β-caryophyllene, β-caryophyllene oxide (from curry leaf), piperine (from black pepper), curcumin, demethoxycurcumin, and bisdemethoxycurcumin (from turmeric) were successfully identified as low molecular inhibitors. This is the first report to determine α- and β-caryophyllene, β-caryophyllene oxide, and piperine as β-secretase inhibitors. These compounds may pass through the blood brain barrier since their molecular weights are relatively low.
Literatur
1.
Zurück zum Zitat Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, Nakazawa H, Yamada T, Okada H, Yamamoto T, Kosaka k (2002) Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 196:63–69PubMedCrossRef Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, Nakazawa H, Yamada T, Okada H, Yamamoto T, Kosaka k (2002) Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 196:63–69PubMedCrossRef
2.
Zurück zum Zitat Williams P, Sorribas A, Howes MJR (2011) Natural products as a source of Alzheimer’s drug leads. Nat Prod Rep 28:48–77PubMedCrossRef Williams P, Sorribas A, Howes MJR (2011) Natural products as a source of Alzheimer’s drug leads. Nat Prod Rep 28:48–77PubMedCrossRef
3.
Zurück zum Zitat Asai M, Hattori C, Iwata N, Saito TC, Sasagawa N, Szabó B, Hashimoto Y, Maruyama K, Tanuma S, Kiso Y (2006) The novel β-Secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice. J Neurochem 96:533–540PubMedCrossRef Asai M, Hattori C, Iwata N, Saito TC, Sasagawa N, Szabó B, Hashimoto Y, Maruyama K, Tanuma S, Kiso Y (2006) The novel β-Secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice. J Neurochem 96:533–540PubMedCrossRef
4.
Zurück zum Zitat Marston A, Kissling J, Hostettmann K (2002) A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants. Phytochem Anal 13:51–54PubMedCrossRef Marston A, Kissling J, Hostettmann K (2002) A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants. Phytochem Anal 13:51–54PubMedCrossRef
5.
Zurück zum Zitat Giovannni SD, Borloz A, Urbain A, Marston A, Hostettmann K, Carrupt PA, Reist M (2008) In vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: thin layer chromatography versus microplate methods. Eur J Pharm Sci 33:109–119CrossRef Giovannni SD, Borloz A, Urbain A, Marston A, Hostettmann K, Carrupt PA, Reist M (2008) In vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: thin layer chromatography versus microplate methods. Eur J Pharm Sci 33:109–119CrossRef
6.
Zurück zum Zitat Sasaki H, Miki K, Kinoshita K, Koyama K, Juliawaty LD, Achmad SA, Hakim EH, Kaneda M, Takahashi K (2010) β-Secretase (BACE-1) inhibitory effect of bioflavonoids. Bioorg Med Chem Lett 20:4558–4560PubMedCrossRef Sasaki H, Miki K, Kinoshita K, Koyama K, Juliawaty LD, Achmad SA, Hakim EH, Kaneda M, Takahashi K (2010) β-Secretase (BACE-1) inhibitory effect of bioflavonoids. Bioorg Med Chem Lett 20:4558–4560PubMedCrossRef
7.
Zurück zum Zitat Zhu Z, Li C, Wang X, Yang Z, Hen J, Hu L, Jiang H, Shen X (2010) 2,2′,4′-Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice. J Neurochem 114:374–385PubMedCrossRef Zhu Z, Li C, Wang X, Yang Z, Hen J, Hu L, Jiang H, Shen X (2010) 2,2′,4′-Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice. J Neurochem 114:374–385PubMedCrossRef
8.
Zurück zum Zitat Rogers S, Doody RS, Pratt RD, Ieni JR (2000) Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol 10:195–203PubMedCrossRef Rogers S, Doody RS, Pratt RD, Ieni JR (2000) Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol 10:195–203PubMedCrossRef
9.
Zurück zum Zitat Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R (2006) 3-Year study of donepezil therapy in Alzheimer’s disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord 21:353–363PubMedCrossRef Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R (2006) 3-Year study of donepezil therapy in Alzheimer’s disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord 21:353–363PubMedCrossRef
10.
Zurück zum Zitat Gevaert T, Vandepitte J, Hutchings G, Vriens J, Nilius B, Ridder DD (2007) TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist. Neurol Urodyn 26:440–450CrossRef Gevaert T, Vandepitte J, Hutchings G, Vriens J, Nilius B, Ridder DD (2007) TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist. Neurol Urodyn 26:440–450CrossRef
11.
Zurück zum Zitat Wang X, Kim JR, Lee SB, Kim YJ, Jung MY, Kwon HW, Ahn YJ (2014) Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer’s disease Drosophila models. BMC Complement Altern Med. doi:10.1186/1472-6882-14-88 Wang X, Kim JR, Lee SB, Kim YJ, Jung MY, Kwon HW, Ahn YJ (2014) Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer’s disease Drosophila models. BMC Complement Altern Med. doi:10.​1186/​1472-6882-14-88
12.
Zurück zum Zitat Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H (2008) Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neurochem 19:1329–1333 Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H (2008) Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neurochem 19:1329–1333
13.
Zurück zum Zitat Huang HC, Tang D, Xu K, Jiang ZF (2014) Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway. J Recept Signal Transduct Res 34:26–37PubMedCrossRef Huang HC, Tang D, Xu K, Jiang ZF (2014) Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway. J Recept Signal Transduct Res 34:26–37PubMedCrossRef
14.
Zurück zum Zitat Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova KG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM (2012) Oral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24 week randomized, double blind, placebo-controlled study. Alzheimer’s Res Ther 4:43–51CrossRef Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova KG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM (2012) Oral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24 week randomized, double blind, placebo-controlled study. Alzheimer’s Res Ther 4:43–51CrossRef
15.
Zurück zum Zitat Casas S, Casini P, Piquer S, Altirriba J, Soty M, Cadavez L, Gomis R, Novials A (2010) BACE2 plays a role in the insulin receptor trafficking in pancreatic β-cells. Am J Physiol Endocrinol Metab 299:E1087–E1095PubMedCrossRef Casas S, Casini P, Piquer S, Altirriba J, Soty M, Cadavez L, Gomis R, Novials A (2010) BACE2 plays a role in the insulin receptor trafficking in pancreatic β-cells. Am J Physiol Endocrinol Metab 299:E1087–E1095PubMedCrossRef
16.
Zurück zum Zitat Stützner I, Selevsek N, Esterházy D, Schmidt A, Aebersold R, Stoffel M (2013) Systematic proteomic analysis identifies β-Site amyloid precursor protein cleaving enzyme 2 and 1 (BACE2 and BACE1) substrates in pancreatic β-cells. J Biol Chem 288:10536–10547CrossRef Stützner I, Selevsek N, Esterházy D, Schmidt A, Aebersold R, Stoffel M (2013) Systematic proteomic analysis identifies β-Site amyloid precursor protein cleaving enzyme 2 and 1 (BACE2 and BACE1) substrates in pancreatic β-cells. J Biol Chem 288:10536–10547CrossRef
Metadaten
Titel
Screening of β-secretase and acetylcholinesterase inhibitors from plant resources
verfasst von
Kazuya Murata
Shinichi Matsumura
Yuri Yoshioka
Yoshihiro Ueno
Hideaki Matsuda
Publikationsdatum
01.01.2015
Verlag
Springer Japan
Erschienen in
Journal of Natural Medicines / Ausgabe 1/2015
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-014-0859-3

Weitere Artikel der Ausgabe 1/2015

Journal of Natural Medicines 1/2015 Zur Ausgabe